Novavax and Serum Institute of India Announce First Emergency Use Authorization of Novavax’ COVID-19 Vaccine in Adolescents ≥12 to <18 in India Read more
Affini-T Therapeutics Completes $175 Million Financing Co-Led by Vida Ventures and Leaps by Bayer to Advance Groundbreaking T Cell Therapies for Solid Tumor Patients with Oncogenic Driver Mutations Read more
Acasti Pharma Announces Patents for GTX-104 in Europe, GTX-102 in the U.S. and GTX-101 in Japan Read more
Pfizer to Supply UNICEF up to 4 Million Treatment Courses of Novel COVID-19 Oral Treatment for Low- and Middle-Income Countries Read more
Proscia and Visiopharm Partner to Deliver AI-Powered Pathology to Drive Insight in Cancer Diagnosis Read more
Sen-Jam Pharmaceutical Partners with Specialty Pharmaceutical Manufacturer to Provide Formulation and Chemistry, Manufacturing & Controls for Covid-19 Oral Therapeutic Read more
Exclusive Speaker Interview with Damien Boyd, MSD Ahead of the Highly Potent API Conference Read more
FDA Approves Merck’s KEYTRUDA (pembrolizumab) for Patients With MSI‑H/dMMR Advanced Endometrial Carcinoma Read more